Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CD257/BAFF/TNFSF13B/BLYS Antibody (R3X64)

Catalog #:   RHJ85301 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, IF, WB
Accession: Q9Y275
Overview

Catalog No.

RHJ85301

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400, IF: 1:100-1:500, WB: 1:500-1:2000

Target

BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9Y275

Applications

ELISA, FCM, IF, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3X64

Data Image
  • Flow Cytometry
    Flow cytometric analysis of HeLa cells using TNFSF13B mouse mAb (green) and negative control (red).
  • Immunofluorescence
    Immunofluorescence analysis of SMMC-7721 cells using TNFSF13B mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.
  • Western blot
    Western blot analysis using TNFSF13B mouse mAb against SK-N-SH (1) and MOLT4 (2) cell lysate.
References

FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and Survival., PMID:39941037

Development and therapeutic assessment of bispecific nanobodies targeting B-cell activating factor and interleukin-17 for the neutralization of inflammatory mediators in autoimmune diseases., PMID:39870268

A first-in-human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults., PMID:39494621

Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia., PMID:39471335

B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus Erythematosus., PMID:39409173

Current status of BAFF targeting immunotherapy in B-cell neoplasm., PMID:39222149

Serum BAFF levels are associated with the prognosis of idiopathic membranous nephropathy., PMID:39143819

Changes in peripheral blood IL-9, Th9, and BAFF levels in patients with allergic rhinitis and their clinical implications., PMID:39093090

B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia., PMID:39047848

Proof-of-concept study evaluating humoral primary immunodeficiencies via CJ:KREC ratio and serum BAFF level., PMID:38906917

Bronchiectasis, lymphadenopathies related to BAFF overexpression and lymphoplasmacytic cystitis as adverse events associated with prolonged use of rituximab in systemic autoimmune rheumatic diseases., PMID:38849075

Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification., PMID:38761670

B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis., PMID:36098792

Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus., PMID:35780200

Serum Soluble B Cell-Activating Factor Is a Non-Invasive Biomarker of Antibody-Mediated Rejection in Kidney Allograft With Satisfactory Risk Stratification Performance But Negligible Diagnostic Value., PMID:35493478

Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren's syndrome patients., PMID:35411715

BAFF rs9514828 gene polymorphism and the risk of the development of inhibitors in children with severe haemophilia A., PMID:35316553

Increased gene expression of B cell-activating factor of tumor necrosis factor family, in remitting antineutrophil cytoplasmic antibody-associated vasculitis patients., PMID:34908244

BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment., PMID:34810198

Possible interplay between estrogen and the BAFF may modify thyroid activity in Graves' disease., PMID:34725405

Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy., PMID:34712223

B Cell-Activating Factor Antagonism Attenuates the Growth of Experimental Abdominal Aortic Aneurysm., PMID:34509440

High B-cell activating factor levels in multi-transfused thalassemia patients., PMID:34396626

B-cell activating factor BAFF as a novel alert marker for the immunological risk stratification after kidney transplantation., PMID:34373996

BAFF receptor polymorphisms and deficiency in humans., PMID:34311146

Keeping up with the stress of antibody production: BAFF and APRIL maintain memory plasma cells., PMID:34303157

10 Years of belimumab experience: What have we learnt?, PMID:34238087

Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease., PMID:34188092

Function, occurrence and inhibition of different forms of BAFF., PMID:34182216

Meant to B: B cells as a therapeutic target in systemic lupus erythematosus., PMID:34128474

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors., PMID:34079038

BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis., PMID:34075170

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen., PMID:34054835

The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas., PMID:34003398

Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection., PMID:33748289

Serum markers of B-cell activation in pregnant women with atopic asthma., PMID:33682259

B cell-activating factor modulates the factor VIII immune response in hemophilia A., PMID:33651716

FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis., PMID:33505402

BAFF, involved in B cell activation through the NF-κB pathway, is related to disease activity and bone destruction in rheumatoid arthritis., PMID:33483588

A longitudinal study of plasma BAFF levels in mothers and their infants in Uganda, and correlations with subsets of B cells., PMID:33465125

B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment., PMID:33339749

Evolutionarily Selected Overexpression of the Cytokine BAFF Enhances Mucosal Immune Response Against P. falciparum., PMID:33123155

Artesunate inhibits Sjögren's syndrome-like autoimmune responses and BAFF-induced B cell hyperactivation via TRAF6-mediated NF-κB signaling., PMID:33086170

The BAFF / APRIL system as therapeutic target in multiple sclerosis., PMID:32900236

Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation., PMID:32849514

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism., PMID:32840410

Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus., PMID:32783382

Associations Between Smoking and Systemic Lupus Erythematosus-Related Cytokines and Chemokines Among US Female Nurses., PMID:32619290

The roles of B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) in allergic asthma., PMID:32522667

Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures., PMID:32506205

Datasheet
$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CD257/BAFF/TNFSF13B/BLYS Antibody (R3X64) [RHJ85301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only